ProQR Therapeutics Ownership 2024 | Who Owns ProQR Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

22.13%

Insider Ownership

18.87%

Retail Ownership

59.00%

Institutional Holders

50.00

ProQR Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRIVIUM FUND MANAGEMENT B.V.6.81%3.27%5,344,446--12,238,781Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.62%0.02%3,625,467--8,301,957Mar 31, 2024
ECOR1 CAPITAL, LLC3.68%0.17%2,884,357-95,659-3.21%6,604,889Mar 31, 2024
M28 CAPITAL MANAGEMENT LP1.30%1.73%1,019,498-891,102-46.64%2,334,548Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC1.15%0.47%905,582-35,000-3.72%2,073,692Mar 31, 2024
MACQUARIE GROUP LTD0.79%0.00%620,000--1,407,000Mar 31, 2024
IKARIAN CAPITAL, LLC0.62%0.12%483,58310,9582.32%1,097,734Mar 31, 2024
DEUTSCHE BANK AG\0.49%0.00%385,149-59-0.02%881,991Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.42%0.00%328,989-120,073-26.74%746,805Mar 31, 2024
MONACO ASSET MANAGEMENT SAM0.40%0.21%312,629-65,847-17.40%709,668Mar 31, 2024
TWO SIGMA ADVISERS, LP0.21%0.00%162,000-6,700-3.97%370,964Mar 31, 2024
SQUAREPOINT OPS LLC0.19%0.00%152,50224,32818.98%346,180Mar 31, 2024
FRANKLIN STREET ADVISORS INC /NC0.19%0.03%150,000--343,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%140,151140,151100.00%318,143Mar 31, 2024
BANK OF AMERICA CORP /DE/0.14%-110,10731,85440.71%252,035,000Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.14%0.00%106,70310,95811.45%244,339Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.10%0.00%78,944-20,547-20.65%180,774Mar 31, 2024
MORGAN STANLEY0.09%-67,591-46,120-40.56%154,777Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.06%-46,671--105,943Mar 31, 2024
CITADEL ADVISORS LLC0.06%-46,008-31,808-40.88%104,438Mar 31, 2024

ProQR Therapeutics's largest institutional shareholder is PRIVIUM FUND MANAGEMENT B.V., holding 6.81% of the company's total share outstanding, currently valued at $12.24M. The top 10 institutional shareholders own together 20.28% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRIVIUM FUND MANAGEMENT B.V.6.81%3.27%5,344,446--12,238,781Mar 31, 2024
M28 CAPITAL MANAGEMENT LP1.30%1.73%1,019,498-891,102-46.64%2,334,548Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC1.15%0.47%905,582-35,000-3.72%2,073,692Mar 31, 2024
MONACO ASSET MANAGEMENT SAM0.40%0.21%312,629-65,847-17.40%709,668Mar 31, 2024
ECOR1 CAPITAL, LLC3.68%0.17%2,884,357-95,659-3.21%6,604,889Mar 31, 2024
IKARIAN CAPITAL, LLC0.62%0.12%483,58310,9582.32%1,097,734Mar 31, 2024
FRANKLIN STREET ADVISORS INC /NC0.19%0.03%150,000--343,000Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.62%0.02%3,625,467--8,301,957Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP0.02%0.00%12,05312,053100.00%27,600Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.14%0.00%106,70310,95811.45%244,339Mar 31, 2024
ATOM INVESTORS LP0.02%0.00%13,107--30,014Mar 31, 2024
CUTLER GROUP LLC / CA0.01%0.00%4,200-400-8.70%9,000Mar 31, 2024
RFG ADVISORY, LLC0.04%0.00%32,00032,000100.00%73,277Mar 31, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.06%0.00%45,00013,05040.85%103,046Mar 31, 2024
MACQUARIE GROUP LTD0.79%0.00%620,000--1,407,000Mar 31, 2024
PFS PARTNERS, LLC0.00%0.00%1,000--2,290Mar 31, 2024
CSENGE ADVISORY GROUP0.01%0.00%10,000--22,899Mar 31, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC0.03%0.00%21,429--49,070Mar 31, 2024
TWO SIGMA ADVISERS, LP0.21%0.00%162,000-6,700-3.97%370,964Mar 31, 2024
SQUAREPOINT OPS LLC0.19%0.00%152,50224,32818.98%346,180Mar 31, 2024

The largest ProQR Therapeutics shareholder by % of total assets is PRIVIUM FUND MANAGEMENT B.V.. The company owns 5.34M shares of ProQR Therapeutics (PRQR), representing 3.27% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%140,151140,151100.00%318,143Mar 31, 2024
RFG ADVISORY, LLC0.04%0.00%32,00032,000100.00%73,277Mar 31, 2024
BANK OF AMERICA CORP /DE/0.14%-110,10731,85440.71%252,035,000Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.03%0.00%24,76324,763100.00%56,000Mar 31, 2024
SQUAREPOINT OPS LLC0.19%0.00%152,50224,32818.98%346,180Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.04%0.00%35,00119,100120.12%80,149Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.02%-16,50016,500100.00%37,455Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.03%0.00%23,73313,096123.12%54,346Mar 31, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.06%0.00%45,00013,05040.85%103,046Mar 31, 2024
CITADEL ADVISORS LLC0.05%-36,00012,60053.85%81,720Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP0.02%0.00%12,05312,053100.00%27,600Mar 31, 2024
SIMPLEX TRADING, LLC0.02%-13,55011,756655.30%30,000Mar 31, 2024
EP WEALTH ADVISORS, LLC0.01%0.00%11,50011,500100.00%26,334Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.14%0.00%106,70310,95811.45%244,339Mar 31, 2024
IKARIAN CAPITAL, LLC0.62%0.12%483,58310,9582.32%1,097,734Mar 31, 2024
CITADEL ADVISORS LLC0.01%-11,80010,200637.50%26,786Mar 31, 2024
UBS GROUP AG0.01%-4,9701,07027.44%11,381Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD--33--75Mar 31, 2024
BLACKROCK INC.0.01%-3,945--9,034Mar 31, 2024
WELLS FARGO & COMPANY/MN0.01%-10,996--25,180,000Mar 31, 2024

As of Mar 31 2024, ProQR Therapeutics's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 140.15K stocks of PRQR, valued at $318.14K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
M28 CAPITAL MANAGEMENT LP1.30%1.73%1,019,498-891,102-46.64%2,334,548Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.42%0.00%328,989-120,073-26.74%746,805Mar 31, 2024
ECOR1 CAPITAL, LLC3.68%0.17%2,884,357-95,659-3.21%6,604,889Mar 31, 2024
MONACO ASSET MANAGEMENT SAM0.40%0.21%312,629-65,847-17.40%709,668Mar 31, 2024
MORGAN STANLEY0.09%-67,591-46,120-40.56%154,777Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC1.15%0.47%905,582-35,000-3.72%2,073,692Mar 31, 2024
CITADEL ADVISORS LLC0.06%-46,008-31,808-40.88%104,438Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.10%0.00%78,944-20,547-20.65%180,774Mar 31, 2024
MARSHALL WACE, LLP----10,085-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%0.00%9,690-8,716-47.35%21,996Mar 31, 2024
TWO SIGMA ADVISERS, LP0.21%0.00%162,000-6,700-3.97%370,964Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----3,536-100.00%-Mar 31, 2024
LAZARD ASSET MANAGEMENT LLC0.01%-4,147-1,713-29.23%9,000Mar 31, 2024
CUTLER GROUP LLC / CA0.01%0.00%4,200-400-8.70%9,000Mar 31, 2024
JPMORGAN CHASE & CO0.00%-1,493-321-17.70%3,389Mar 31, 2024
DEUTSCHE BANK AG\0.49%0.00%385,149-59-0.02%881,991Mar 31, 2024
PRIVIUM FUND MANAGEMENT B.V.6.81%3.27%5,344,446--12,238,781Mar 31, 2024
FRANKLIN STREET ADVISORS INC /NC0.19%0.03%150,000--343,000Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.4.62%0.02%3,625,467--8,301,957Mar 31, 2024
ATOM INVESTORS LP0.02%0.00%13,107--30,014Mar 31, 2024

As of Mar 31 2024, ProQR Therapeutics's biggest institutional seller is M28 CAPITAL MANAGEMENT LP. The company sold -0.89M shares of PRQR, valued at $2.33M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%140,151140,151100.00%318,143Mar 31, 2024
RFG ADVISORY, LLC0.04%0.00%32,00032,000100.00%73,277Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.03%0.00%24,76324,763100.00%56,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.02%-16,50016,500100.00%37,455Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP0.02%0.00%12,05312,053100.00%27,600Mar 31, 2024
EP WEALTH ADVISORS, LLC0.01%0.00%11,50011,500100.00%26,334Mar 31, 2024

ProQR Therapeutics's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 140.15K shares, valued at $318.14K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MARSHALL WACE, LLP----10,085-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----3,536-100.00%-Mar 31, 2024

ProQR Therapeutics's largest sold out institutional shareholder by shares sold is MARSHALL WACE, LLP, sold -10.09K shares, valued at -, as of undefined.

ProQR Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
DRIEHAUS MUTUAL FUNDS0.03%223,726--Dec 29, 2023
ALPS ETF Trust0.01%69,542--Feb 29, 2024
Brinker Capital Destinations Trust0.00%300,452--Feb 29, 2024
VANGUARD WHITEHALL FUNDS0.00%146,867--Jan 31, 2024
RBB FUND, INC.0.00%126,755--Feb 29, 2024
Direxion Shares ETF Trust0.00%27,145--Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%63,953--Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.00%205--Dec 31, 2023
NORTHERN FUNDS0.00%6,172--Dec 29, 2023
AMERICAN CENTURY ETF TRUST0.00%18598112.64%Feb 29, 2024

ProQR Therapeutics's largest mutual fund holder by % of total assets is "DRIEHAUS MUTUAL FUNDS", owning 223.73K shares, compromising 0.03% of its total assets.

ProQR Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24506.38%
31 Dec, 23476.82%
30 Sep, 2344-15.38%
30 Jun, 2352-5.45%
31 Mar, 235514.58%
31 Dec, 22484.35%
30 Sep, 2246-6.12%
30 Jun, 2249-25.76%
31 Mar, 2266-15.38%
31 Dec, 217813.04%
30 Sep, 21699.52%
30 Jun, 2163-8.70%
31 Mar, 216943.75%
31 Dec, 204814.29%
30 Sep, 2042-6.67%
30 Jun, 2045-2.17%
31 Mar, 2046-9.80%
31 Dec, 19514.08%
30 Sep, 1949-12.50%
30 Jun, 19563.70%
31 Mar, 1954-5.26%
31 Dec, 185762.86%
30 Sep, 183540.00%
30 Jun, 18254.17%
31 Mar, 1824-4.00%
31 Dec, 172513.64%
30 Sep, 172222.22%
30 Jun, 1718-10.00%
31 Mar, 1720-9.09%
31 Dec, 1622-12.00%
30 Sep, 1625-3.85%
30 Jun, 1626-10.34%
31 Mar, 1629-9.38%
31 Dec, 1532-8.57%
30 Sep, 1535-2.78%
30 Jun, 1536-5.26%
31 Mar, 15388.57%
31 Dec, 143516.67%
30 Sep, 1430-

As of 31 Mar 24, 50 institutions are holding ProQR Therapeutics's shares, representing an increase of 6.38% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2417,361,552-5.53%
31 Dec, 2318,377,505-1.60%
30 Sep, 2318,675,674-11.64%
30 Jun, 2321,135,789-5.25%
31 Mar, 2322,307,77435.08%
31 Dec, 2216,514,578-22.26%
30 Sep, 2221,242,505-3.93%
30 Jun, 2222,112,155-30.38%
31 Mar, 2231,763,460-36.69%
31 Dec, 2150,172,77026.37%
30 Sep, 2139,703,5223.29%
30 Jun, 2138,438,045-11.39%
31 Mar, 2143,381,18564.24%
31 Dec, 2026,413,798-5.71%
30 Sep, 2028,012,830-3.73%
30 Jun, 2029,096,888-0.77%
31 Mar, 2029,323,602-2.69%
31 Dec, 1930,133,44039.10%
30 Sep, 1921,662,813-8.32%
30 Jun, 1923,627,913-1.55%
31 Mar, 1924,000,2663.88%
31 Dec, 1823,104,62618.39%
30 Sep, 1819,515,60776.30%
30 Jun, 1811,069,7863.72%
31 Mar, 1810,672,500-7.02%
31 Dec, 1711,478,42813.91%
30 Sep, 1710,077,12011.93%
30 Jun, 179,003,272-0.08%
31 Mar, 179,010,1161.36%
31 Dec, 168,889,1192.26%
30 Sep, 168,692,509-5.01%
30 Jun, 169,151,395-4.99%
31 Mar, 169,632,200-13.92%
31 Dec, 1511,189,7230.47%
30 Sep, 1511,137,8062.79%
30 Jun, 1510,835,771-1.63%
31 Mar, 1511,015,14037.38%
31 Dec, 148,018,2015.12%
30 Sep, 147,627,734-

ProQR Therapeutics (PRQR) has 17.36M shares outstanding as of 31 Mar 24, down -5.53% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2422.13%4.30%
31 Dec, 2322.69%4.26%
30 Sep, 2323.07%3.38%
30 Jun, 2326.13%3.44%
31 Mar, 2327.58%5.19%
31 Dec, 2223.05%2.60%
30 Sep, 2229.76%3.10%
30 Jun, 2230.99%1.56%
31 Mar, 2244.51%0.90%
31 Dec, 2170.43%2.08%
30 Sep, 2158.16%1.72%
30 Jun, 2158.11%0.80%
31 Mar, 2185.38%3.07%
31 Dec, 2052.76%1.69%
30 Sep, 2055.87%1.65%
30 Jun, 2058.17%1.68%
31 Mar, 2058.76%1.09%
31 Dec, 1973.43%2.37%
30 Sep, 1955.67%1.51%
30 Jun, 1960.73%1.59%
31 Mar, 1961.72%1.34%
31 Dec, 1867.85%1.98%
30 Sep, 1858.51%4.87%
30 Jun, 1834.67%3.10%
31 Mar, 1833.43%1.63%
31 Dec, 1745.24%2.85%
30 Sep, 1739.86%2.83%
30 Jun, 1737.53%2.55%
31 Mar, 1738.38%2.65%
31 Dec, 1638.07%2.75%
30 Sep, 1637.23%2.42%
30 Jun, 1639.20%2.30%
31 Mar, 1641.26%1.80%
31 Dec, 1547.94%2.11%
30 Sep, 1547.71%2.21%
30 Jun, 1546.42%2.08%
31 Mar, 1547.20%4.00%
31 Dec, 1434.36%3.22%
30 Sep, 1432.68%-

As of 31 Mar 24, ProQR Therapeutics is held by 22.13% institutional shareholders, representing a 4.30% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 241416.67%
31 Dec, 23129.09%
30 Sep, 2311-45.00%
30 Jun, 2320-41.18%
31 Mar, 233436.00%
31 Dec, 222556.25%
30 Sep, 2216-30.43%
30 Jun, 2223-39.47%
31 Mar, 2238-15.56%
31 Dec, 214518.42%
30 Sep, 213811.76%
30 Jun, 2134-27.66%
31 Mar, 214795.83%
31 Dec, 202450.00%
30 Sep, 2016-33.33%
30 Jun, 202426.32%
31 Mar, 2019-50.00%
31 Dec, 193880.95%
30 Sep, 1921-8.70%
30 Jun, 1923-8.00%
31 Mar, 1925-35.90%
31 Dec, 183977.27%
30 Sep, 182283.33%
30 Jun, 181220.00%
31 Mar, 1810-28.57%
31 Dec, 1714-
30 Sep, 171455.56%
30 Jun, 17950.00%
31 Mar, 176-33.33%
31 Dec, 16912.50%
30 Sep, 168-20.00%
30 Jun, 1610-16.67%
31 Mar, 1612-14.29%
31 Dec, 1514-33.33%
30 Sep, 152110.53%
30 Jun, 1519-20.83%
31 Mar, 152420.00%
31 Dec, 1420-33.33%
30 Sep, 1430-

14 institutional shareholders have increased their position in PRQR stock as of 31 Mar 24 compared to 12 in the previous quarter (a 16.67% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 241427.27%
31 Dec, 231110.00%
30 Sep, 231011.11%
30 Jun, 239125.00%
31 Mar, 234-71.43%
31 Dec, 2214-17.65%
30 Sep, 221721.43%
30 Jun, 2214-6.67%
31 Mar, 2215-34.78%
31 Dec, 212335.29%
30 Sep, 21176.25%
30 Jun, 211677.78%
31 Mar, 219-35.71%
31 Dec, 2014-17.65%
30 Sep, 201741.67%
30 Jun, 2012-33.33%
31 Mar, 2018100.00%
31 Dec, 199-25.00%
30 Sep, 1912-33.33%
30 Jun, 191820.00%
31 Mar, 191515.38%
31 Dec, 181330.00%
30 Sep, 181066.67%
30 Jun, 18620.00%
31 Mar, 185-16.67%
31 Dec, 17620.00%
30 Sep, 175400.00%
30 Jun, 171-80.00%
31 Mar, 175-28.57%
31 Dec, 167-36.36%
30 Sep, 161110.00%
30 Jun, 161011.11%
31 Mar, 169-25.00%
31 Dec, 151250.00%
30 Sep, 158-38.46%
30 Jun, 151344.44%
31 Mar, 159-18.18%
31 Dec, 1411-
30 Sep, 14--

14 institutional shareholders have reduced their position in PRQR stock as of 31 Mar 24 compared to 11 in the previous quarter (a 27.27% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24506.38%17,361,552-5.53%22.13%4.30%1416.67%1427.27%
31 Dec, 23476.82%18,377,505-1.60%22.69%4.26%129.09%1110.00%
30 Sep, 2344-15.38%18,675,674-11.64%23.07%3.38%11-45.00%1011.11%
30 Jun, 2352-5.45%21,135,789-5.25%26.13%3.44%20-41.18%9125.00%
31 Mar, 235514.58%22,307,77435.08%27.58%5.19%3436.00%4-71.43%
31 Dec, 22484.35%16,514,578-22.26%23.05%2.60%2556.25%14-17.65%
30 Sep, 2246-6.12%21,242,505-3.93%29.76%3.10%16-30.43%1721.43%
30 Jun, 2249-25.76%22,112,155-30.38%30.99%1.56%23-39.47%14-6.67%
31 Mar, 2266-15.38%31,763,460-36.69%44.51%0.90%38-15.56%15-34.78%
31 Dec, 217813.04%50,172,77026.37%70.43%2.08%4518.42%2335.29%
30 Sep, 21699.52%39,703,5223.29%58.16%1.72%3811.76%176.25%
30 Jun, 2163-8.70%38,438,045-11.39%58.11%0.80%34-27.66%1677.78%
31 Mar, 216943.75%43,381,18564.24%85.38%3.07%4795.83%9-35.71%
31 Dec, 204814.29%26,413,798-5.71%52.76%1.69%2450.00%14-17.65%
30 Sep, 2042-6.67%28,012,830-3.73%55.87%1.65%16-33.33%1741.67%
30 Jun, 2045-2.17%29,096,888-0.77%58.17%1.68%2426.32%12-33.33%
31 Mar, 2046-9.80%29,323,602-2.69%58.76%1.09%19-50.00%18100.00%
31 Dec, 19514.08%30,133,44039.10%73.43%2.37%3880.95%9-25.00%
30 Sep, 1949-12.50%21,662,813-8.32%55.67%1.51%21-8.70%12-33.33%
30 Jun, 19563.70%23,627,913-1.55%60.73%1.59%23-8.00%1820.00%
31 Mar, 1954-5.26%24,000,2663.88%61.72%1.34%25-35.90%1515.38%
31 Dec, 185762.86%23,104,62618.39%67.85%1.98%3977.27%1330.00%
30 Sep, 183540.00%19,515,60776.30%58.51%4.87%2283.33%1066.67%
30 Jun, 18254.17%11,069,7863.72%34.67%3.10%1220.00%620.00%
31 Mar, 1824-4.00%10,672,500-7.02%33.43%1.63%10-28.57%5-16.67%
31 Dec, 172513.64%11,478,42813.91%45.24%2.85%14-620.00%
30 Sep, 172222.22%10,077,12011.93%39.86%2.83%1455.56%5400.00%
30 Jun, 1718-10.00%9,003,272-0.08%37.53%2.55%950.00%1-80.00%
31 Mar, 1720-9.09%9,010,1161.36%38.38%2.65%6-33.33%5-28.57%
31 Dec, 1622-12.00%8,889,1192.26%38.07%2.75%912.50%7-36.36%
30 Sep, 1625-3.85%8,692,509-5.01%37.23%2.42%8-20.00%1110.00%
30 Jun, 1626-10.34%9,151,395-4.99%39.20%2.30%10-16.67%1011.11%
31 Mar, 1629-9.38%9,632,200-13.92%41.26%1.80%12-14.29%9-25.00%
31 Dec, 1532-8.57%11,189,7230.47%47.94%2.11%14-33.33%1250.00%
30 Sep, 1535-2.78%11,137,8062.79%47.71%2.21%2110.53%8-38.46%
30 Jun, 1536-5.26%10,835,771-1.63%46.42%2.08%19-20.83%1344.44%
31 Mar, 15388.57%11,015,14037.38%47.20%4.00%2420.00%9-18.18%
31 Dec, 143516.67%8,018,2015.12%34.36%3.22%20-33.33%11-
30 Sep, 1430-7,627,734-32.68%-30---

ProQR Therapeutics Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
SPROSpero Therapeutics, Inc.
TILInstil Bio, Inc.
NUVBNuvation Bio Inc.
NXTCNextCure, Inc.
ALNYAlnylam Pharmaceuticals, Inc.
WVEWave Life Sciences Ltd.
DAWNDay One Biopharmaceuticals, Inc.
ARWRArrowhead Pharmaceuticals, Inc.
ANNXAnnexon, Inc.
BPMCBlueprint Medicines Corporation
CTMXCytomX Therapeutics, Inc.
ACHLAchilles Therapeutics plc
APLSApellis Pharmaceuticals, Inc.
NLTXNeurogene Inc.
ASMBAssembly Biosciences, Inc.

PRQR Ownership FAQ


ProQR Therapeutics is owned by institutional shareholders (22.13%), insiders (18.87%), and public (59.00%). The largest institutional shareholder of ProQR Therapeutics is PRIVIUM FUND MANAGEMENT B.V. (6.81% of total shares) and the top mutual fund owner is DRIEHAUS MUTUAL FUNDS (0.03% of total shares).

ProQR Therapeutics's major institutional shareholders are PRIVIUM FUND MANAGEMENT B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., ECOR1 CAPITAL, LLC, M28 CAPITAL MANAGEMENT LP, and DAFNA CAPITAL MANAGEMENT LLC. The top five shareholders own together 17.56% of the company's share outstanding.

As of Mar 2024, there are 50 institutional shareholders of ProQR Therapeutics.

PRIVIUM FUND MANAGEMENT B.V owns 5.34M shares of ProQR Therapeutics, representing 6.81% of the company's total shares outstanding, valued at $12.24M (as of Mar 2024).

As of Mar 2024, ADAGE CAPITAL PARTNERS GP, L.L.C holds 3.63M shares of ProQR Therapeutics (PRQR), compromising 4.62% of the company, valued at $8.3M.

ECOR1 CAPITAL, LLC is the third largest holder of ProQR Therapeutics. The company owns 2.88M of the company's shares outstanding (worth $6.6M).